Skip to content
Sign in

PALI · NASDAQ

Palisade Bio (PALI) Stock Price & Fundamentals

$390.32−0.33%−$1.28End-of-day price as of Oct 9, 2026

Palisade Bio (PALI) closed at $390.32 on Oct 9, 2026, down 0.33% from the previous close of $391.60.

Share price, past year

1Y +78.73%

52-week range $218.39 – $392.02. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$390.32
Sep 30, 2026$386.54
Aug 31, 2026$368.49
Jul 31, 2026$323.76
Jun 30, 2026$312.24
May 29, 2026$307.38
Apr 30, 2026$296.83
Mar 31, 2026$294.02
Feb 27, 2026$287.78
Jan 30, 2026$274.89
Dec 31, 2025$273.53
Nov 28, 2025$245.13
Oct 31, 2025$234.52

Key statistics

Market cap
$67.76B
P/E (TTM)
600.5
EPS (TTM)
$0.65
Revenue (TTM)
$500.00K
Net income (TTM)
−$31.94M
Shares outstanding
173.6M
Dividend yield
—
52-week range
$218.39 – $392.02

Palisade Bio's market cap is $67.76B, based on a share price of $390.32 and 173.6M shares outstanding as of Jun 30, 2026.

Financials

Palisade Bio reported revenue of $0.00 for fiscal 2025.

Palisade Bio reported a net loss of $16.78M in fiscal 2025.

Annual revenue

FY15FY16FY17FY18FY19FY20FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Palisade Bio annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$0.00—−$16.78M—−$0.30—
FY2024ended Dec 31, 2024$0.00−100.0%−$14.44M—−$10.19−$12.19M
FY2023ended Dec 31, 2023$250.00K—−$12.30M−4,920.0%−$27.01−$11.14M
FY2022ended Dec 31, 2022$0.00−100.0%−$14.26M—−$16.53−$13.37M
FY2020ended Dec 31, 2020$13.52K−12.2%−$10.32M−76,346.2%−$3.72−$4.77M
FY2019ended Dec 31, 2019$15.39K−94.1%−$8.35M−54,252.6%−$3.80—
FY2018ended Dec 31, 2018$260.00K0.0%−$4.92M−1,894.1%−$7.54−$7.69M
FY2017ended Dec 31, 2017$260.00K+1,500.4%−$15.67M−6,025.4%−$1.20−$13.43M
FY2016ended Dec 31, 2016$16.25K+56.0%−$21.07M−129,721.9%−$2.53−$15.71M
FY2015ended Dec 31, 2015$10.42K—————
Palisade Bio quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$500.00K−$10.57M−$0.05
Q1 FY2026ended Mar 31, 2026$0.00−$9.60M−$0.05
Q4 FY2025ended Dec 31, 2025$0.00−$8.90M$1.13
Q3 FY2025ended Sep 30, 2025$0.00−$2.87M−$0.38
Q2 FY2025ended Jun 30, 2025$0.00−$2.78M−$0.58
Q1 FY2025ended Mar 31, 2025$0.00−$2.23M−$0.47
Q4 FY2024ended Dec 31, 2024$0.00−$3.34M$0.04
Q3 FY2024ended Sep 30, 2024$0.00−$3.49M−$2.32

Company profile

Name
Palisade Bio, Inc.
Ticker
PALI
Exchange
NASDAQ
Industry (SEC SIC)
Biological Products, (No Diagnostic Substances)
Headquarters
7750 El Camino Real, Suite 5200, Carlsbad, CA 92009
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001357459

Recent SEC filings

Frequently asked questions

What is Palisade Bio's stock price?

Palisade Bio (PALI) closed at $390.32 on Oct 9, 2026, down 0.33% from the previous close of $391.60.

What is Palisade Bio's market cap?

Palisade Bio's market cap is $67.76B, based on a share price of $390.32 and 173.6M shares outstanding as of Jun 30, 2026.

How much revenue does Palisade Bio make?

Palisade Bio reported revenue of $0.00 for fiscal 2025.

What is PALI's P/E ratio?

Palisade Bio's price-to-earnings ratio is 600.5, based on trailing twelve-month diluted EPS of $0.65.

Does Palisade Bio pay a dividend?

Palisade Bio's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Palisade Bio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures